The ongoing NAFTA renegotiations could put a Canadian national pharmacare program in jeopardy, and have a particular impact on Canadians who need expensive arthritis drugs. Here's how.
As Canadians consider possibilities for pharmacare reform in the coming months, they should have access to the best available evidence about how it might work in our country.
The cost of a life-saving drug in Canada is rising by 3,000 per cent. A national pharmacare plan could bring order to this chaotic world of Canadian drug prices.
Will Ottawa's new advisory council on pharmacare amount to "just another study," or is a national program truly within reach?
Canada is the only nation with a broad public health system lacking universal coverage for pharmaceuticals. Despite fears that pharmacare would be too costly, it could end up saving Canadians money.